Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
10.50
-0.57
-5.43%
Share Warrants & Outstandings
Total Reserve
-24.79
7.65
-32.44
-424.05%
Shareholder's Funds
-14.87
18.15
-33.02
-181.93%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.00
18.53
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.00
18.53
0.00%
Deferred Tax Assets / Liabilities
-0.90
0.00
-0.90
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
17.62
0.00
17.62
0.00%
Current Liabilities
Trade Payables
2.57
0.02
2.55
12,750.00%
Other Current Liabilities
1.79
0.27
1.52
562.96%
Short Term Borrowings
3.05
0.00
3.05
0.00%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
10.15
0.29
9.86
3,400.00%
Total Liabilities
12.91
18.44
-5.53
-29.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
3.07
24.69
804.23%
Less: Accumulated Depreciation
22.49
0.00
22.49
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
3.07
2.20
71.66%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.00
0.01
0.00%
Long Term Loans & Advances
1.29
0.00
1.29
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
6.57
3.07
3.50
114.01%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
0.00
4.13
0.00%
Sundry Debtors
1.41
0.00
1.41
0.00%
Cash and Bank
0.04
15.15
-15.11
-99.74%
Other Current Assets
0.74
0.18
0.56
311.11%
Short Term Loans and Advances
0.02
0.04
-0.02
-50.00%
Total Current Assets
6.34
15.37
-9.03
-58.75%
Net Current Assets (Including Current Investments)
-3.81
15.08
-18.89
-125.27%
Total Current Assets Excluding Current Investments
6.34
15.37
-9.03
-58.75%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
18.44
-5.53
-29.99%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.58
0.00
21.58
0.00%
Book Value per share (adjusted)
-14.98
3.46
-18.44
-532.95%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
